+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Comprehensive analysis of genes involved in the malignancy of gastrointestinal stromal tumors

Comprehensive analysis of genes involved in the malignancy of gastrointestinal stromal tumors

Anticancer Research 30(7): 2705-2715

During tumorigenesis of gastrointestinal stromal tumors (GISTs), the most frequent changes are reported to be gain-of-function mutations in the C-KIT proto-oncogene. However, we speculated that additional genetic alterations are required for the progression of GISTs. Using 15 cases diagnosed with GISTs, we searched for novel indicator genes by microarray analyses using an Oligo GEArray(R) PI3K-AKT Signaling Pathway Microarray Kit. In addition, we analyzed the mutational status of C-KIT and the proliferation status indicated by the Ki-67 index. The tumor localizations of the 15 GISTs were as follows: 8 in the stomach; 2 in the small intestine; 2 in the mesentery; 1 in the duodenum; 1 in the rectum; and 1 in liver. Regarding the C-KIT gene analysis, mutations in exon 11 were detected in 11 out of 13 patients. In 1 out of the 13 patients, mutations were detected in both exons 11 and 13. No genetic abnormalities were identified in 1 patient. The Ki-67 labeling indices were significantly lower for the low-risk and intermediate-risk groups than for the high-risk group (p=0.0440). No specific genes were overexpressed in the >1% Ki-67 group. Regarding the primary lesion sites, the following 6 genes were overexpressed in tumors in the stomach: RBL2, RHOA, SHC1, HSP90AB1, ACTB and BAS2C. Gene analysis is currently only useful for diagnostic assessment and predicting therapeutic effects. However, it may be possible for new malignancy-related factors to be identified by comparing and investigating gene expression levels and other factors using such analyses.

Please choose payment method:

(PDF emailed within 1 workday: $29.90)

Accession: 052269786

Download citation: RISBibTeXText

PMID: 20683002

Related references

Cytomorphology of gastrointestinal stromal tumors and extra-gastrointestinal stromal tumors: A comprehensive morphologic study. Journal of Cytology 30(1): 8-12, 2013

Immunohistochemistry and c-kit gene analysis in determining malignancy in gastrointestinal stromal tumors. Hepato-Gastroenterology 50(53): 1431-1435, 2003

Diagnostic morphological features of PDGFRA-mutated gastrointestinal stromal tumors: molecular genetic and histologic analysis of 60 cases of gastric gastrointestinal stromal tumors. Annals of Diagnostic Pathology 11(1): 27-33, 2007

Mutational analysis of CASP1, 2, 3, 4, 5, 6, 7, 8, 9, 10, and 14 genes in gastrointestinal stromal tumors. Human Pathology 40(6): 868-871, 2009

Identification of key genes related to high-risk gastrointestinal stromal tumors using bioinformatics analysis. Journal of Cancer Research and Therapeutics 14(Supplement): S243-S247, 2018

Identification of key genes and associated pathways in KIT/PDGFRA wild‑type gastrointestinal stromal tumors through bioinformatics analysis. Molecular Medicine Reports 18(5): 4499-4515, 2018

Gastrointestinal stromal tumors of the stomach: CT findings and prediction of malignancy. Ajr. American Journal of Roentgenology 183(4): 893-898, 2004

A novel correlation between LINE-1 hypomethylation and the malignancy of gastrointestinal stromal tumors. Clinical Cancer Research 16(21): 5114-5123, 2011

Study on malignancy, staging, and grading for gastrointestinal stromal tumors. Journal of Clinical Oncology 26(15_suppl): 21521-21521, 2016

Evaluation of malignancy using Ki-67, p53, EGFR and COX-2 expressions in gastrointestinal stromal tumors. World Journal of Gastroenterology 18(20): 2569-2575, 2012

Evaluation of malignancy and prognosis of gastrointestinal stromal tumors: A review. Human Pathology 33(5): 478-483, 2002

Array comparative genomic hybridization analysis of chromosomal imbalances and their target genes in gastrointestinal stromal tumors. Genes, Chromosomes and Cancer 46(6): 564-576, 2007

Correlation of imatinib resistance with the mutational status of KIT and PDGFRA genes in gastrointestinal stromal tumors: a meta-analysis. Journal of Gastrointestinal and Liver Diseases 22(4): 413-418, 2014

Gastrointestinal stromal tumors: a comprehensive review. Journal of Gastrointestinal Oncology 10(1): 144-154, 2019

Cancer biology of small gastrointestinal stromal tumors (<2 cm): What is the risk of malignancy?. European Journal of Surgical Oncology 43(7): 1344-1349, 2017